non invasive 20blood 20glucose 20 measuring 20system
TRANSCRIPT
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
1/24
Non-Invasive Blood Glucose Measuring System
Department of Electronics & ECE
Prof. Swapna Banerjee
n an nst tute o ec no ogy, aragpur
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
2/24
Diabetes Mellitus
A metabolic disorder in which our body is unable toregulate the level of glucose in the blood
Most prevalent non-communicable disease
More than 150 million diabetic patients in the world
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
3/24
Management of diabetes
Diabetes related long term complications are leadingcause of death
The complications can be reduced by 50-75% by tighterg ycem c contro
Frequent monitoring Ad ustin the medical nutritional thera , exercise
and medications to prevent hyper- or hypoglycemia
(Source : The Diabetes Control and Complications Trial Research Group, The effect of intensive treatment of diabetes on the develo ment and ro ression of lon terms com lications in insulin-de endent diabetes mellitus N. Engl. J. Med. 329(14), 977-986 (1993))
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
4/24
Present technique of monitoring blood glucose
Either invasive or minimally invasive
e ng o - ne me o s-Time consumingLabour intensiveMay not reflect real-time status of the glucosecan cause cell contamination
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
5/24
Shortcomings of invasive method
Painful
High recurring cost
Potential source of spread of diseases like Hepatitis,HIV through contact with bodily fluids
Continuous monitoring not possible
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
6/24
Why non-invasive method ?
Will remove all shortcomings of present techniquesIm rove ualit of life
Reduce complications and mortality associated withthe disease
Possibility of developing artificial pancreas
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
7/24
Potential non-invasive optical methods
Infrared and Near-infrared absorption spectroscopy
Near-infrared scattering technique
Polarimetry techniqueRaman spectroscopy
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
8/24
Photoacoustic MethodM d l d l b
Excited state
Modulated laser beam
AbsorptionRadiativebsorption
p
of lighttransition
Non-radiativetransition
Sampleressure wave
A h A
Ground stateAcoustic transducer
heat A A
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
9/24
Factors affecting PA generation
Nanosecond PulsedLaser Beam
Skin and Tissue
WavelengthPulse Wid th, PRF
Ei
: Incident optical energya : Absorption coefficientd : Length of the cylinder within the sample
occu ied b the o tical beam
Local Absorptionglucose molecules
RadiativeRelaxation
Flourescence,
Optical absorption coeff. Cp : Specific heat capacity for a constant pressure : Density of the medium
V : Illuminated volume at room temperaturer : Radius of the optical beam
V C d E
T p
aiLocal TemperatureIncrease
Adiabatic
Phosphorescence
Specific heat capacityVol . expansion coeff.
: Volumetric thermal expansion coefficient ofthe medium
T : Rise in temperatureB : Bulk modulus
2
2
.. r
EC
vV C d E
B t B p ai aiPressure Wave
Generation
Speed of sound
v : pee o soun n e me um
/ Bv Transducer type &Dimension
Pressure DetectionTransducer
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
10/24
Dependence of PA signal on glucoseconcentration
2ai
p
2
rE.
Cvp
More immune to scattering
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
11/24
Phases of development
The total development process has been planned intwo phases
Phase I
Validation of the technique with glucose solution
Phase II A lication on human sub ect
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
12/24
- invasive blood glucose monitoring system
Pulse Driver
DIGITAL SIGNAL PROCESSING BLOCKS
Generator Circuit
LaserDiode
PiezoelectricTransducer
Low NoiseAmplifier
na og toDigital
Converter
SignalAverager
Fast FourierTransform
Digital PeakDetector
Disply
Calibration
CorrectionFactors
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
13/24
System Photograph
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
14/24
Choice of components
Acoustic signal detectorSensitive
uggeInsensitive to changes in ambient conditions
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
15/24
Choice of wavelength
905nm905 nm
905 nm wavelength gives desired depth of penetration and absorption by
Water and other constitutes of blood are less compared to glucose.
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
16/24
Absorption profile of glucose
1
GC
M
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
17/24
Comparison between 905 nm and 1064 nm
Parameter 905 nm 1064 nm
Absorption in tissue Slightly higher thanat 1064nm
Lower than at905nm
Reduced scattering coefficient Low Almost equal
Effective penetration depth Second highest Highest(2.5mm) (3.5mm)
Absorption in water 0.007 mm -1 0.015mm -1
Absor tion in lucose Low Ver hi h
Sensitivity to oxy-hemoglobinand deoxy-hemoglobin
Less High
ower ou pu o aser o e wa wa
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
18/24
Optical source and acoustic detector
Optical sourcePulsed Laser diode having = 905 nm
Pulse width : ~100 ns
Pulse repetition frequency : ~100 HzPulse energy : Less than 0.1 J/Sq. cm.
Acoustic DetectorPiezoelectric material (PZT-5A) from Panametrics, USA
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
19/24
Transducer selection table
LiNbO3
PZT-5A PVDF
Piezoelectric
d 33 (10-12 C/N) 6 400 .39~.44constant
g 33 (Vm/N) 0.023 0.025 -0.32
Mechanical Q factor 100 75 5~103 . .
Sound velocity (m/s) 7316 4500 2260
Acoustic impedance(10 6k m 2s
33 35 4
Work temperature( 0C)
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
20/24
Application on human bodyeasur ng g ucose rom uman o y s qu e comp ex ue o w e
range of potentially interfering components. A number of factorsthat are to be considered for developing such a system :
a p ca s gna :Depth of penetration at least upto dermis layer of skin
Higher absorption by glucose compared to other constitutes of blood, water, protein, fat, melanin etc.Optical energy within the Maximum Permissible Engergy (MPE) asspecified in Safe use of lasers for health care facilities, - ANSI
Standard Z 136.3-2005 Pulse width and pulse repetition frequency meeting PA generationcondition.Test site (e.g. finger, earlobe etc.)
Optical signal delivery mechanism
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
21/24
Phase-I : Glucose solutionarrie out PA measurement at 1 4 nm using
Nd:YAG laser with glucose solution of differentconcentrations
Result : Peak-to-peak value of the PA signal maintains a nearly linearrelationship with the concentration of glucose in the solution.
Conclusion : Can be considered for developing a non-invasive blood
glucose monitor
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
22/24
Phase II: on human subject with OGTT
0.6
0.7
0.8
0.4
0.5
A s
i g n a
l ( m V )
Point of drinking
0.1
0.2
.
0 5 10 15 20 25 30 35 400Time (minute)
Variation of PA signal plotted with digitized signal captured through oscilloscope
Finding : Result closely matches the pattern of variation after consumptionof glucose by a subject with the result reported in the literature
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
23/24
concentration
79
80
76
77
l i n m v
73
74 P A s
i g n
100 105 110 115 120 125 130 135 14070
71
Blood lucose level in m /dl
Blood glucose values measured with SMBG monitor ACCU CHEK Active
-
8/6/2019 Non Invasive 20Blood 20Glucose 20 Measuring 20System
24/24
Further work needed to realize the system
Although results achieved so far are quite encouraging, but needsfurther extensive testing and improvement in the design before it can
Modification of the front-end circuitryDesign of laser driver circuit
in FPGA Nullify the sources of error due to change in
Pressure
Temperature (both ambient and body)Melanin content of the skinOxygen saturation of bloodSubject dependent tissue condition at the test site (finger)
Any other physiological conditions